Hyaluronic Acid-based Dermal Fillers Market Size, Share & Trends Analysis Report By Product, By Application (Wrinkle Removal, Lip Augmentation, Rhinoplasty), By Region, And Segment Forecasts, 2019 - 2026

Published: Nov, 2019 | Pages: 120 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)

The global hyaluronic acid-based dermal fillers market size is expected to reach USD 5.9 billion by 2026, based on a new report by Grand View Research, Inc., registering a 7.4% CAGR during the forecast period. Rising emphasis on physical appearances, increasing demand from the aging population to look young and fit, and growing awareness regarding minimally invasive aesthetic procedures with faster recovery is expected to boost market growth during the forecast period.

Hyaluronic acid fillers are one of the highly recommended injectable procedures by dermatologists across the world due to their biodegradable nature. A wide range of products are available in the market for various cosmetic procedures such as wrinkle removal, lip augmentation, restoration of volume and contour, scar removal, hydration, and rhinoplasty. Manufacturers are heavily investing in product development and marketing to expand their product life cycle and their position in the market. For instance, in May 2018, Nestlé Skin Health received the U.S. FDA approval for Restylane Lyft for correction of volume and wrinkles on the back of hands in patients aged 21 and older, making it the first-ever FDA approved product of its kind for hands, or areas other than the face.

Successful marketing of products, brand recognition, and peer recommendation are key factors aiding companies in gaining market share. For instance, in 2017, Croma Pharma rebranded its Princess line of hyaluronic acid dermal fillers to Saypha, which includes products such as Saypha Rich, Filler, Volume, and Volume Plus to create a strong global brand. Similarly, Prollenium Medical Technologies, a Canadian company, launched Revanesse Versa in January 2018, which is one the latest dermal fillers approved by the U.S. FDA. The product is recommended for lip augmentation and wrinkle removal procedures and promises minimal post-injection swelling due to uniform and smooth solution.

Further key findings from the study suggest:

• Hyaluronic acid fillers account for a majority share in the overall injectable dermal fillers market owing to their high compatibility with the human body and easy reversibility of the procedure

• Single-phase products dominated the market in 2018 and are projected to grow at a steady rate during the forecast period. This can be attributed to benefits such as longevity and desirable effects delivered by these products 

• Lucrative growth in the lip augmentation segment is attributed to rising influence of social media, especially on the population aged 18 to 35 years. Moreover, hyaluronic acid fillers are the most preferred injectables due to faster recovery time, negligible side effects, and economic cost of the procedure

• North America held the largest market share in 2018 owing to easy product availability in this region and versatile application of the same in cosmetic and aesthetic medicinal procedures

• Improvements in healthcare facilities due to rapid economic development in countries such as China, Japan, and South Korea have made Asia Pacific the most lucrative market. Dermal filler treatments are in high demand in these countries and are being performed in beauty clinics and spas, mainly in urban areas

• Successful marketing of products, brand recognition, and peer recommendation are key factors aiding companies in gaining market share. Some of the key industry contributors are Allergan; Galderma Laboratories L.P; Merz Pharmaceuticals; Genzyme Corporation; Anika Therapeutics Inc.; LG Life Sciences, LTD (LG Chem); Bioplus Co. Ltd.; Sculpt Luxury Dermal Fillers Ltd; Bioxis Pharmaceutical; Sinclair Pharma; Laboratories Vivacy; and Bohus Biotech AB.

 Table of Contents

Chapter 1 Methodology and Scope
                   1.1 Market Segmentation & Scope
                       1.1.1 Product
                       1.1.2 Application
                       1.1.3 Regional Scope
                       1.1.4 Estimates And Forecast Timeline
                   1.2 Research Methodology
                   1.3 Information Procurement
                       1.3.1 Purchased Database
                       1.3.2 Gvr’s Internal Database
                       1.3.3 Secondary Sources
                       1.3.4 Primary Research
                       1.3.5 Details Of Primary Research
                   1.4 Information or Data Analysis
                       1.4.1 Data Analysis Models
                   1.5 Market Formulation & Validation
                   1.6 Model Details
                       1.6.1 Volume Price Analysis
                       1.6.2 Commodity Flow Analysis
                   1.7 List of Secondary Sources
                   1.8 List of Abbreviations
                   1.9 Objectives
                       1.9.1 Objective 1
                       1.9.2 Objective 2

Chapter 2 Executive Summary
                   2.1 Market Outlook
                   2.2 Segment Outlook
                       2.2.1 Product
                       2.2.2 Application
                       2.2.3 Region
                   2.3 Competitive Insights

Chapter 3 Market Variables, Trends & Scope
                   3.1 Market Lineage Outlook
                       3.1.1 Parent Market Outlook
                       3.1.2 Related/Ancillary Market Outlook
                   3.2 Market Segmentation
                   3.3 User Perspective Analysis
                       3.3.1 Consumer Behavior Analysis
                       3.3.2 Market Influencer Analysis
                   3.4 Penetration & Growth Prospect Mapping
                       3.4.1 Analysis
                   3.5 Market Dynamics
                       3.5.1 Market Driver Analysis
                           3.5.1.1 Increasing geriatric population
                           3.5.1.2 Growing demand for anti-aging solutions and minimally invasive aesthetic treatment
                           3.5.1.3 Growing applications in regenerative medicine and tissue engineering
                       3.5.2 Market Restraint Analysis
                           3.5.2.1 High cost and side effects associated with hyaluronic acid cycles
                   3.6 Business Environment Analysis Tools
                       3.6.1 Porter’s Five Forces Analysis
                       3.6.2 Hyaluronic Acid Dermal Fillers Market - Pestle Analysis
                   3.7 Clinical Trials
                   3.8 Major Deals & Strategic Alliances Analysis
                       3.8.1 Licensing & Partnerships, Technology Collaborations
                       3.8.2 Mergers & Acquisitions

Chapter 4 Hyaluronic Acid-Based Dermal Fillers Market: Product Analysis
                   4.1 Hyaluronic Acid-Based Dermal Fillers Product Market Share analysis, 2018 & 2026
                   4.2 Segment Dashboard
                   4.3 Market Size & Forecasts and Trend Analysis, 2015 to 2026 for the Product
                       4.3.1 Single-Phase Product
                           4.3.1.1 Single-phase product market, 2015 - 2026 (USD Million)
                       4.3.2 Duplex Product
                           4.3.2.1 Duplex product market, 2015 - 2026 (USD Million)

Chapter 5 Hyaluronic Acid-Based Dermal Fillers Market: Application Analysis
                   5.1 Hyaluronic Acid-Based Dermal Fillers Application Market Share analysis, 2018 & 2026
                   5.2 Segment Dashboard
                   5.3 Market Size & Forecasts and Trend Analysis, 2015 to 2026 for the Application
                       5.3.1 Wrinkle Removal
                           5.3.1.1 Wrinkle removal market, 2015 - 2026 (USD Million)
                       5.3.2 Lip Augmentation
                           5.3.2.1 Lip augmentation market, 2015 - 2026 (USD Million)
                       5.3.3 Rhinoplasty
                           5.3.3.1 Rhinoplasty market, 2015 - 2026 (USD Million)
                       5.3.4 Others
                           5.3.4.1 Others market, 2015 - 2026 (USD Million)

Chapter 6 Regional Outlook
                   6.1 Regional Market Share Analysis, 2018 & 2026
                   6.2 Regional Market Dashboard
                   6.3 Regional Market Snapshot (Countries)
                   6.4 Market Size & Forecasts and Trend Analysis, 2018 to 2026
                       6.4.1 North America
                           6.4.1.1 North America hyaluronic acid-based dermal fillers market, 2015 - 2026 (USD Million)
                           6.4.1.2 U.S.
                               6.4.1.2.1 U.S. hyaluronic acid-based dermal fillers market, 2015 - 2026 (USD Million)
                           6.4.1.3 Canada
                               6.4.1.3.1 Canada hyaluronic acid-based dermal fillers market, 2015 - 2026 (USD Million)
                       6.4.2 Europe
                           6.4.2.1 Europe hyaluronic acid-based dermal fillers market, 2015 - 2026 (USD Million)
                           6.4.2.2 U.K.
                               6.4.2.2.1 U.K. hyaluronic acid-based dermal fillers market, 2015 - 2026 (USD Million)
                           6.4.2.3 Germany
                               6.4.2.3.1 Germany hyaluronic acid-based dermal fillers market, 2015 - 2026 (USD Million)
                           6.4.2.4 France
                               6.4.2.4.1 France hyaluronic acid-based dermal fillers market, 2015 - 2026 (USD Million)
                           6.4.2.5 Italy
                               6.4.2.5.1 Italy hyaluronic acid-based dermal fillers market, 2015 - 2026 (USD Million)
                           6.4.2.6 Spain
                               6.4.2.6.1 Spain hyaluronic acid-based dermal fillers market, 2015 - 2026 (USD Million)
                       6.4.3 Asia Pacific
                           6.4.3.1 Asia Pacific hyaluronic acid-based dermal fillers market, 2015 - 2026 (USD Million)
                           6.4.3.2 Japan
                               6.4.3.2.1 Japan hyaluronic acid-based dermal fillers market, 2015 - 2026 (USD Million)
                           6.4.3.3 China
                               6.4.3.3.1 China hyaluronic acid-based dermal fillers market, 2015 - 2026 (USD Million)
                           6.4.3.4 India
                               6.4.3.4.1 India hyaluronic acid-based dermal fillers market, 2015 - 2026 (USD Million)
                           6.4.3.5 South Korea
                               6.4.3.5.1 South Korea hyaluronic acid-based dermal fillers market, 2015 - 2026 (USD Million)
                       6.4.4 Latin America
                           6.4.4.1 Latin America hyaluronic acid-based dermal fillers market, 2015 - 2026 (USD Million)
                           6.4.4.2 Brazil
                               6.4.4.2.1 Brazil hyaluronic acid-based dermal fillers market, 2015 - 2026 (USD Million)
                           6.4.4.3 Mexico
                               6.4.4.3.1 Mexico hyaluronic acid-based dermal fillers market, 2015 - 2026 (USD Million)
                       6.4.5 Middle East & Africa
                           6.4.5.1 MEA hyaluronic acid-based dermal fillers market, 2015 - 2026 (USD Million)
                           6.4.5.2 South Africa
                               6.4.5.2.1 South africa hyaluronic acid-based dermal fillers market, 2015 - 2026 (USD Million)

Chapter 7 Competitive Analysis
                   7.1 Strategic Framework/ Competition Categorization (Key innovators, Market leaders, emerging players
                   7.2 Vendor Landscape
                       7.2.1 Company Market Position Analysis (Market Presence, Geographic Presence, Product Portfolio, Startegic Initiatves)
                   7.3 Company Profiles
                       7.3.1 ALLERGAN
                           7.3.1.1 Company overview
                           7.3.1.2 Financial performance
                           7.3.1.3 Product benchmarking
                           7.3.1.4 Strategic initiatives
                           7.3.1.5 SWOT analysis
                       7.3.2 GALDERMA LABORATORIES L.P.
                           7.3.2.1 Company overview
                           7.3.2.2 Financial performance
                           7.3.2.3 Product benchmarking
                           7.3.2.4 Strategic initiatives
                           7.3.2.5 SWOT analysis
                       7.3.3 MERZ PHARMACEUTICALS
                           7.3.3.1 Company overview
                           7.3.3.2 Financial performance
                           7.3.3.3 Product benchmarking
                           7.3.3.4 Strategic initiatives
                       7.3.4 GENZYME CORPORATION
                           7.3.4.1 Company overview
                           7.3.4.2 Financial performance
                           7.3.4.3 Product benchmarking
                           7.3.4.4 SWOT analysis
                       7.3.5 ANIKA THERAPEUTICS, INC.
                           7.3.5.1 Company overview
                           7.3.5.2 Financial performance
                           7.3.5.3 Product benchmarking
                           7.3.5.4 Strategic initiatives
                           7.3.5.5 SWOT analysis
                       7.3.6 LG LIFE SCIENCES, LTD. (LG CHEM.)
                           7.3.6.1 Company overview
                           7.3.6.2 Financial performance
                           7.3.6.3 Product benchmarking
                           7.3.6.4 Strategic initiative
                           7.3.6.5 SWOT analysis
                       7.3.7 BIOPLUS CO., LTD.
                           7.3.7.1 Company overview
                           7.3.7.2 Product benchmarking
                           7.3.7.3 Strategic initiatives
                       7.3.8 SCULPT LUXURY DERMAL FILLERS LTD
                           7.3.8.1 Company overview
                           7.3.8.2 Product benchmarking
                       7.3.9 BIOXIS PHARMACEUTICALS
                           7.3.9.1 Company overview
                           7.3.9.2 Product benchmarking
                           7.3.9.3 Strategic initiative
                       7.3.10 SINCLAIR PHARMA
                           7.3.10.1 Company overview
                           7.3.10.2 Product benchmarking
                           7.3.10.3 Strategic initiatives
                       7.3.11 LABORATOIRES VIVACY
                           7.3.11.1 Company overview
                           7.3.11.2 Product benchmarking
                           7.3.11.3 Strategic initiatives
                       7.3.12 BOHUS BIOTECH AB
                           7.3.12.1 Company overview
                           7.3.12.2 Product benchmarking

Chapter 8 KoL Commentary and Recommendations
                   8.1 KoL Commentary
                   8.2 Recommendations

List of Tables

TABLE 1 List of secondary sources
TABLE 2 List of abbreviation
TABLE 3 List of China Food and Drug Administration (CFDA) approved HA dermal fillers
TABLE 4 North America HA dermal filler market, by country, 2015 - 2026 (USD Million)
TABLE 5 North America HA dermal filler market, by product, 2015 - 2026 (USD Million)
TABLE 6 North America HA dermal filler market, by application, 2015 - 2026 (USD Million)
TABLE 7 U.S. HA dermal filler market, by product, 2015 - 2026 (USD Million)
TABLE 8 U.S. HA dermal filler market, by application, 2015 - 2026 (USD Million)
TABLE 9 Canada HA dermal filler market, by product, 2015 - 2026 (USD Million)
TABLE 10 Canada HA dermal filler market, by application, 2015 - 2026 (USD Million)
TABLE 11 Europe HA dermal filler market, by country, 2015 - 2026 (USD Million)
TABLE 12 Europe HA dermal filler market, by product, 2015 - 2026 (USD Million)
TABLE 13 Europe HA dermal filler market, by application, 2015 - 2026 (USD Million)
TABLE 14 U.K. HA dermal filler market, by product, 2015 - 2026 (USD Million)
TABLE 15 U.K. HA dermal filler market, by application, 2015 - 2026 (USD Million)
TABLE 16 Germany HA dermal filler market, by product, 2015 - 2026 (USD Million)
TABLE 17 Germany HA dermal filler market, by application, 2015 - 2026 (USD Million)
TABLE 18 France HA dermal filler market, by product, 2015 - 2026 (USD Million)
TABLE 19 France HA dermal filler market, by application, 2015 - 2026 (USD Million)
TABLE 20 Italy HA dermal filler market, by product, 2015 - 2026 (USD Million)
TABLE 21 Italy HA dermal filler market, by application, 2015 - 2026 (USD Million)
TABLE 22 Spain HA dermal filler market, by product, 2015 - 2026 (USD Million)
TABLE 23 Spain HA dermal filler market, by application, 2015 - 2026 (USD Million)
TABLE 24 Asia Pacific HA dermal filler market, by country, 2015 - 2026 (USD Million)
TABLE 25 Asia Pacific HA dermal filler market, by product, 2015 - 2026 (USD Million)
TABLE 26 Asia Pacific HA dermal filler market, by application, 2015 - 2026 (USD Million)
TABLE 27 Japan HA dermal filler market, by product, 2015 - 2026 (USD Million)
TABLE 28 Japan HA dermal filler market, by application, 2015 - 2026 (USD Million)
TABLE 29 China HA dermal filler market, by product, 2015 - 2026 (USD Million)
TABLE 30 China HA dermal filler market, by application, 2015 - 2026 (USD Million)
TABLE 31 India HA dermal filler market, by product, 2015 - 2026 (USD Million)
TABLE 32 India HA dermal filler market, by application, 2015 - 2026 (USD Million)
TABLE 33 South Korea HA dermal filler market, by product, 2015 - 2026 (USD Million)
TABLE 34 South Korea HA dermal filler market, by application, 2015 - 2026 (USD Million)
TABLE 35 Latin America HA dermal filler market, by country, 2015 - 2026 (USD Million)
TABLE 36 Latin America HA dermal filler market by product, 2015 - 2026 (USD Million)
TABLE 37 Latin America HA dermal filler market by application, 2015 - 2026 (USD Million)
TABLE 38 Brazil HA dermal filler market, by product, 2015 - 2026 (USD Million)
TABLE 39 Brazil HA dermal filler market, by application, 2015 - 2026 (USD Million)
TABLE 40 Mexico HA dermal filler market by product, 2015 - 2026 (USD Million)
TABLE 41 Mexico HA dermal filler market by application, 2015 - 2026 (USD Million)
TABLE 42 MEA HA dermal filler market country, 2015 - 2026 (USD Million)
TABLE 43 MEA HA dermal filler market product, 2015 - 2026 (USD Million)
TABLE 44 MEA HA dermal filler market application, 2015 - 2026 (USD Million)
TABLE 45 South Africa HA dermal filler market, by product, 2015 - 2026 (USD Million)
TABLE 46 South Africa HA dermal filler market, by application, 2015 - 2026 (USD Million)

List of Figures

FIG. 1 Market research process
FIG. 2 Data triangulation techniques
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value-chain-based sizing & forecasting
FIG. 6 QFD modeling for market share assessment
FIG. 7 Market formulation & validation
FIG. 8 Hyaluronic acid based dermal fillers market summary, 2018 (USD Million)
FIG. 9 Hyaluronic acid-based dermal fillers market segmentation
FIG. 10 Penetration & growth prospect mapping
FIG. 11 Market trends & outlook
FIG. 12 Market driver relevance analysis (Current & future impact)
FIG. 13 Ratio of adult population to total population (Billion)
FIG. 14 Market restraint relevance analysis (Current & future impact)
FIG. 15 Porter's five forces analysis
FIG. 16 PESTEL analysis
FIG. 17 Hyaluronic acid based dermal fillers market: Product movement analysis
FIG. 18 Hyaluronic acid product outlook: Key takeaways
FIG. 19 Single-phase product market, 2015 - 2026 (USD Million)
FIG. 20 Duplex product market, 2015 - 2026 (USD Million)
FIG. 21 Hyaluronic acid based dermal fillers market: Application movement analysis
FIG. 22 Hyaluronic acid based dermal fillers application outlook: Key takeaways
FIG. 23 Wrinkle removal market, 2015 - 2026 (USD Million)
FIG. 24 Lip augmentation market, 2015 - 2026 (USD Million)
FIG. 25 Rhinoplasty market, 2015 - 2026 (USD Million)
FIG. 26 Others market, 2015 - 2026 (USD Million)
FIG. 27 Regional outlook, 2018 & 2026
FIG. 28 Regional marketplace: Key takeaways
FIG. 29 Regional market snapshot
FIG. 30 North America hyaluronic acid-based dermal fillers market, 2015 - 2026 (USD Million)
FIG. 31 U.S. hyaluronic acid-based dermal fillers market, 2015 - 2026 (USD Million)
FIG. 32 Canada hyaluronic acid-based dermal fillers market, 2015 - 2026 (USD Million)
FIG. 33 Europe hyaluronic acid-based dermal fillers market, 2015 - 2026 (USD Million)
FIG. 34 U.K. hyaluronic acid-based dermal fillers market, 2015 - 2026 (USD Million)
FIG. 35 Germany hyaluronic acid-based dermal fillers market, 2015 - 2026 (USD Million)
FIG. 36 France hyaluronic acid-based dermal fillers market, 2015 - 2026 (USD Million)
FIG. 37 Italy hyaluronic acid-based dermal fillers market, 2015 - 2026 (USD Million)
FIG. 38 Spain hyaluronic acid-based dermal fillers market, 2015 - 2026 (USD Million)
FIG. 39 Asia Pacific hyaluronic acid-based dermal fillers market, 2015 - 2026 (USD Million)
FIG. 40 Japan hyaluronic acid-based dermal fillers market, 2015 - 2026 (USD Million)
FIG. 41 China hyaluronic acid-based dermal fillers market, 2015 - 2026 (USD Million)
FIG. 42 India hyaluronic acid-based dermal fillers market, 2015 - 2026 (USD Million)
FIG. 43 South Korea hyaluronic acid-based dermal fillers market, 2015 - 2026 (USD Million)
FIG. 44 Latin America hyaluronic acid-based dermal fillers market, 2015 - 2026 (USD Million)
FIG. 45 Brazil hyaluronic acid-based dermal fillers market, 2015 - 2026 (USD Million)
FIG. 46 Mexico hyaluronic acid-based dermal fillers market, 2015 - 2026 (USD Million)
FIG. 47 MEA hyaluronic acid-based dermal fillers market, 2015 - 2026 (USD Million)
FIG. 48 South Africa hyaluronic acid-based dermal fillers market, 2015 - 2026 (USD Million)
FIG. 49 Strategy framework
FIG. 50 Market position analysis
FIG. 51 KoL commentary